Predictive factors that influence the course of medullary thyroid carcinoma
- 6 July 2013
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 19 (3) , 445-451
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinomaCurrent Opinion in Oncology, 2012
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III TrialJournal of Clinical Oncology, 2012
- Survival Implications of Cervical Lymphadenectomy in Patients with Medullary Thyroid CancerAnnals of Surgical Oncology, 2010
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid AssociationThyroid®, 2009
- New therapeutic approaches to treat medullary thyroid carcinomaNature Clinical Practice Endocrinology & Metabolism, 2008
- Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patientsEuropean Journal of Surgical Oncology, 2007
- Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinomaSurgery, 2005
- Early Diagnosis and Curative Therapy of Medullary Thyroid Carcinoma by Routine Measurement of Serum Calcitonin in Patients with Thyroid DisordersThyroid®, 2005
- Postoperative calcitonin study in medullary thyroid carcinoma.Endocrine-Related Cancer, 2004
- Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysisCancer, 2000